ライフサイエンスコーパス: cycloplegic

1 Examinations included cycloplegic (1% cyclopentolate) autorefraction, and meas

2 Tropicamide (1%) is an effective cycloplegic agent in myopic children.

3 Although cycloplegic and corticosteroid therapy may resolve some

4 The non-cycloplegic and cycloplegic measurements were strongly c

5 Each patient underwent non-cycloplegic and cycloplegic refraction assessments using

6 Non-cycloplegic and cycloplegic refractive errors, best corr

7 Cycloplegic and manifest refraction were performed on 44

8 tudy aimed to evaluate the agreement between cycloplegic and non-cycloplegic measurements obtained us

9 The agreement between cycloplegic and non-cycloplegic measurements was assesse

10 on of children with < 1-D difference between cycloplegic and PlusOptix A09 refraction was 68.8 %, hig

11 after SMILE surgery, and a higher degree of cycloplegic and topographic cylinder and longer incision

12 In addition, the interaction effects of cycloplegic and topographic cylinder power and longer in

13 ed visual acuity as well as non-cycloplegic, cycloplegic, and subjective refraction.

14 Ellipsoid refraction aligned better non-cycloplegic (ARK-1 = 1.00; 2WIN = 1.74) than with cyclop

15 orithm included antiglaucoma medications and cycloplegics as first-line methods; the second-line ther

16 quivalent differed between PlusOptix A09 and cycloplegic autorefraction (+0.54 [1.82] D vs +1.06 [2.0

17 he 3.2% who were hyperopes >= + 2.00D by non-cycloplegic autorefraction (27.7 +/- 14.7) and for those

18 leted a comprehensive examination, including cycloplegic autorefraction (cyclopentolate 1%; Canon RK-

19 Cycloplegic autorefraction (cyclopentolate 1%; Canon RK-

20 al meridians of the right eye as measured by cycloplegic autorefraction (n = 45 children).

21 09 refraction was positively correlated with cycloplegic autorefraction (r = 0.81, p < 0.001) with hi

22 difference between the spherical equivalent cycloplegic autorefraction 30 degrees in the nasal visua

23 difference between the spherical equivalent cycloplegic autorefraction 30 degrees in the nasal visua

24 trial is progression of myopia determined by cycloplegic autorefraction after inducement of cyclopleg

25 In addition to measures of myopia by cycloplegic autorefraction and AL by A-scan ultrasonogra

26 equivalent refraction (SER) was measured by cycloplegic autorefraction and axial length (AXL) by par

27 Cycloplegic autorefraction and axial length measurements

28 e exams at baseline and 12 months, including cycloplegic autorefraction and axial length.

29 ewish boys (age 8.6 +/- 1.4 years) underwent cycloplegic autorefraction and axial-length measurement.

30 Eye examinations included cycloplegic autorefraction and ocular biometric measures

31 comprehensive ocular examination, including cycloplegic autorefraction and ocular biometry.

32 pal meridian in the right eye as measured by cycloplegic autorefraction at any visit after baseline u

33 r evaluations that included axial length and cycloplegic autorefraction at the beginning and after 1

34 , 6-11 years) with spherical equivalent (SE) cycloplegic autorefraction between -0.75 D and -4.50 D w

35 6 to 11 years with spherical equivalent (SE) cycloplegic autorefraction between -0.75 diopters (D) an

36 uivalent refraction of both eyes obtained by cycloplegic autorefraction between the baseline and 5-ye

37 Refractive error (cycloplegic autorefraction confirmed by retinoscopy), be

38 Children were followed up with cycloplegic autorefraction every 4 months over 2 years.

39 nd a comprehensive eye examination including cycloplegic autorefraction from 100 census tracts.

40 1 incident myopes (-0.75 D or more myopia on cycloplegic autorefraction in both meridians) and 587 em

41 Cycloplegic autorefraction is appropriate to use in pedi

42 ol-based studies assessing hyperopia through cycloplegic autorefraction or cycloplegic retinoscopy.

43 a onset in the right eye was the right eye's cycloplegic autorefraction spherical refractive error va

44 sOptix A09 refraction is closer to that with cycloplegic autorefraction than non-cycloplegic autorefr

45 h distance and near visual acuities plus non-cycloplegic autorefraction using a Shin-Nippon NVision-K

46 when evaluating the cylindrical component of cycloplegic autorefraction versus cycloplegic retinoscop

47 The mean spherical equivalent measured by cycloplegic autorefraction was -2.38 +/- 0.81 D.

48 an (SD) difference between PlusOptix A09 and cycloplegic autorefraction was higher with hyperopia tha

49 tumbling-E charts in 3997 to 5949 children; cycloplegic autorefraction was performed and best correc

50 th ages 9 and 14 years, ocular biometry, and cycloplegic autorefraction were assessed.

51 Thirteen of the 15 studies comparing cycloplegic autorefraction with cycloplegic retinoscopy

52 ridians -0.75 diopters [D] or more myopia by cycloplegic autorefraction) in the Collaborative Longitu

53 ory, colour vision, gross stereopsis and non-cycloplegic autorefraction) were conducted on 81% of a p

54 -0.75 D or more myopia in both meridians (by cycloplegic autorefraction).

55 corneal curvatures were measured annually by cycloplegic autorefraction, and axial length was measure

56 ide school-based eye examinations, including cycloplegic autorefraction, and caregiver-administered q

57 Cycloplegic autorefraction, conjunctival ultraviolet aut

58 cluding monocular VA testing, cover testing, cycloplegic autorefraction, fundus evaluation, and VA re

59 xamination, including BCVA measurement, post-cycloplegic autorefraction, ocular biometry, tonometry,

60 al clinical cases to confirm the accuracy of cycloplegic autorefraction, particularly when corrected

61 relation between Plusoptix photoscreener and cycloplegic autorefraction, the need for cycloplegic dro

62 Using cycloplegic autorefraction, video-based phakometry, and

63 visual field was measured annually by using cycloplegic autorefraction.

64 interviews and ocular examinations including cycloplegic autorefraction.

65 Refractive error was determined by cycloplegic autorefraction.

66 ifference using noncycloplegic compared with cycloplegic autorefraction.

67 newest version of Plusoptix (model 12) with cycloplegic autorefraction.

68 hat with cycloplegic autorefraction than non-cycloplegic autorefraction.

69 D) and emmetropic status were determined by cycloplegic autorefraction.

70 The refractive error was measured using cycloplegic autorefraction.

71 luded assessment of logMAR visual acuity and cycloplegic autorefraction.

72 Comparisons of noncycloplegic with cycloplegic autorefractions found that noncyloplegic ref

73 der were determined using noncycloplegic and cycloplegic autorefractions.

74 al coherence tomographer was used to measure cycloplegic ciliary muscle thicknesses at 1 mm (CMT1), 2

75 Refractive error under cycloplegic conditions and axial length were assessed fr

76 -up examination included refractometry under cycloplegic conditions.

77 l without correction, and retested with full cycloplegic correction when retest criteria were met.

78 Visual acuity was retested with full cycloplegic correction when retest criteria were met.

79 Cycloplegics, corticosteroids, and nonsteroidal anti-inf

80 d and corrected visual acuity as well as non-cycloplegic, cycloplegic, and subjective refraction.

81 group (P = 0.015), while a higher degree of cycloplegic cylinder power, steeper corneal curvature, g

82 and cycloplegic autorefraction, the need for cycloplegic drops in refractive examination of children

83 To evaluate the cycloplegic effect of 1% tropicamide in myopic children

84 irst time, and 14,259 were referred for full cycloplegic examination if they met specific refractive

85 UPVP performed 6779 cycloplegic examinations on this population.

86 Nine healthy cycloplegic eyes with habitual SAs of different signs an

87 y assigned to glasses (1.00 D less than full cycloplegic hyperopia) versus observation and followed e

88 with the addition of topical steroids and/or cycloplegics in eyes that demonstrated anterior chamber

89 te the agreement between cycloplegic and non-cycloplegic measurements obtained using a photoscreener

90 While the cycloplegic measurements obtained with the 2WIN photoscr

91 The agreement between cycloplegic and non-cycloplegic measurements was assessed using paired t-tes

92 The non-cycloplegic and cycloplegic measurements were strongly correlated betwee

93 cover testing, best corrected visual acuity, cycloplegic objective refraction, slit lamp as well as f

94 rror between + 1.51 and - 5.69 diopters (non-cycloplegic) participated (n = 27 in summer, and n = 23

95 ere compared by histology, laser micrometry, cycloplegic photorefractions, and partial coherence inte

96 The spherical equivalent value with non-cycloplegic PlusOptix A09 refraction is closer to that w

97 Further work is needed to characterize the cycloplegic properties of this route of administration.

98 plegic (ARK-1 = 1.00; 2WIN = 1.74) than with cycloplegic refraction (ARK-1 = 1.43; 2WIN = 1.90).

99 evaluating the accuracy and precision of non-cycloplegic refraction and biometric measurements is cli

100 (best-corrected visual acuity, stereoacuity, cycloplegic refraction and funduscopy).

101 Preflight and postflight cycloplegic refraction and ocular biometry measurements

102 predetermined refractive criteria following cycloplegic refraction and received eyeglasses through t

103 nt a comprehensive eye examination including cycloplegic refraction and sensorimotor testing within 6

104 es measured were changes in axial length and cycloplegic refraction as well as subjective rating of v

105 Each patient underwent non-cycloplegic and cycloplegic refraction assessments using the 2WIN photos

106 Examinations included cycloplegic refraction by retinoscopy, keratometry measu

107 nder manifest condition and subsequently for cycloplegic refraction by Topcon KR-1 tabletop autorefra

108 2011 to 2020 and compared their longitudinal cycloplegic refraction data to that of infants with ROP

109 Longitudinal (0-7 years) cycloplegic refraction data were collected prospectively

110 Out of total, 44% of them considered cycloplegic refraction essential under 12 years and 56%

111 er, whether they could be used for assessing cycloplegic refraction has not been examied.

112 h and 12 month follow-up visits, with a mean cycloplegic refraction SE of + 0.5 +/- 0.31 D in group A

113 As a result, cycloplegic refraction should be done for Smartphone abu

114 ngen, Germany) after vision tests and before cycloplegic refraction tests.

115 Each subject underwent a second cycloplegic refraction using the other agent on a separa

116 The spherical equivalent of cycloplegic refraction was + 0.60 +/- 1.57 diopters (D)

117 The average spherical equivalence of cycloplegic refraction was + 6.0 diopters (D).

118 For the right eye, mean cycloplegic refraction was +15.09 diopters (D) (range 9.

119 Cycloplegic refraction was -1.00 diopter in both eyes pr

120 Cycloplegic refraction was completed in 15 051 children

121 Cycloplegic refraction was measured at baseline and 10 y

122 age who were undergoing general anesthesia, cycloplegic refraction was measured using streak retinos

123 Cycloplegic refraction was measured with an auto-refract

124 Cycloplegic refraction was used to identify hyperopia (>

125 Ophthalmologic or optometric cycloplegic refraction were measured.

126 Measurements of peripheral refraction and cycloplegic refraction were obtained at three visits ove

127 signed to overminus spectacles (-2.50 D over cycloplegic refraction) or observation (non-overminus sp

128 vided as spectacles (prescription based on a cycloplegic refraction) that were worn for the first tim

129 est-corrected distance visual acuity (BCVA), cycloplegic refraction, and axial length (AL) measuremen

130 change in the DQ, uncorrected visual acuity, cycloplegic refraction, and corneal status 12, 24, and 3

131 angle of resolution (logMAR) visual acuity, cycloplegic refraction, and funduscopic optic nerve appe

132 Cycloplegic refraction, axial length (AL), accommodation

133 Data collected included age, gender, race, cycloplegic refraction, axial length (AL), keratometry (

134 Cycloplegic refraction, axial length, accommodation ampl

135 strabismus was excluded. Age, visual acuity, cycloplegic refraction, glasses prescriptions, deviation

136 of the best corrected visual acuity (BCVA), cycloplegic refraction, ocular deviation, strabismus as

137 on, corrected distance visual acuity (CDVA), cycloplegic refraction, slitlamp biomicroscopy, and kera

138 All of the participants underwent full cycloplegic refraction, spectacle best-corrected distanc

139 cy was evaluated by comparison to results of cycloplegic refraction.

140 d for spectacle correction was determined by cycloplegic refraction.

141 then completed an eye examination, including cycloplegic refraction.

142 btracting peripheral refraction from central cycloplegic refraction.

143 iological studies with limited resources for cycloplegic refraction.

144 xamination, including dilated fundoscopy and cycloplegic refraction.

145 al acuity testing, stereoacuity testing, and cycloplegic refraction.

146 were followed for a total of 6 years; their cycloplegic refractions and axial length were measured.

147 severe ROP should be monitored with periodic cycloplegic refractions and provided with early optical

148 Cycloplegic refractions culled from medical records were

149 We included cycloplegic refractions from 789 cumulative visits over

150 Manifest refractions, cycloplegic refractions, uncorrected and best-corrected

151 The results were compared to the subjects' cycloplegic refractions.

152 ith keratometry, A-scan ultrasonography, and cycloplegic refractions.

153 t that AL/CR ratio is highly correlated with cycloplegic refractive error and detects myopia with hig

154 Participants underwent cycloplegic refractive error and ocular biometry measure

155 Cycloplegic refractive error and ocular components measu

156 Presence of hyperopia was defined based on cycloplegic refractive error in the worse eye.

157 Accuracy of pre-cycloplegic refractive error measurements was often larg

158 d sixty-two children (71%) were eligible for cycloplegic refractive error measurements.

159 logMAR chart with tumbling-E optotypes, and cycloplegic refractive error using NIDEK autorefractor w

160 Cycloplegic refractive error was measured in 75 Labrador

161 Cycloplegic refractive error was measured with an autore

162 Accommodative response and cycloplegic refractive error were measured by autorefrac

163 Non-cycloplegic and cycloplegic refractive errors, best corrected visual acu

164 Cycloplegic refractive state (Rx), vitreous chamber dept

165 After 11 days of treatment, cycloplegic refractive state and axial component dimensi

166 of 0.5% tropicamide were used to obtain the cycloplegic refractive status of each participant.

167 Ocular developmental assessment, including cycloplegic refractometry, axial length, Cardiff acuity,

168 th treatment randomized by infant, underwent cycloplegic retinoscopic refraction at a mean age of 2(1

169 ears) with and without hyperopia (defined as cycloplegic retinoscopy >= + 1.00D and less than + 5.00D

170 equivalent refractive error was measured by cycloplegic retinoscopy (cyclopentolate 1%).

171 Refractive development was assessed by cycloplegic retinoscopy and A-scan ultrasonography.

172 vision screening referral criteria underwent cycloplegic retinoscopy and ophthalmoscopy by the on-sit

173 Spot (0.806) and excellent agreement between cycloplegic retinoscopy and Plusoptix (0.898).

174 2WIN refraction was compared to dry and cycloplegic retinoscopy and Retinomax.

175 equivalents indicated good agreement between cycloplegic retinoscopy and Spot (0.806) and excellent a

176 sion improvement with pinhole, underwent non-cycloplegic retinoscopy and subjective refraction.

177 Cycloplegic retinoscopy can be valuable in individual cl

178 001 for both) but was in good agreement with cycloplegic retinoscopy for cylinder power and axis.

179 significantly more myopic measurements than cycloplegic retinoscopy for the sphere and spherical equ

180 es comparing cycloplegic autorefraction with cycloplegic retinoscopy found a mean difference in spher

181 tinoscopy under anesthesia was within 1 D of cycloplegic retinoscopy in 25 subjects (61%) for the sph

182 the accuracy of autorefraction compared with cycloplegic retinoscopy in children.

183 nce between retinoscopy under anesthesia and cycloplegic retinoscopy in children.

184 The photorefractors correlated with cycloplegic retinoscopy refractive findings for sphere a

185 nce between retinoscopy under anesthesia and cycloplegic retinoscopy was -0.98 diopters (D) (95% limi

186 ination included visual acuity (VA) testing, cycloplegic retinoscopy with subjective refinement if in

187 Change in SER (cycloplegic retinoscopy) from baseline to 36 months.

188 Cycloplegic retinoscopy, A-scan ultrasonography, slit la

189 Compared with cycloplegic retinoscopy, both devices underestimated hyp

190 velopment was assessed every 2 to 3 weeks by cycloplegic retinoscopy, keratometry and corneal videoto

191 effects of continuous light were assessed by cycloplegic retinoscopy, keratometry, and A-scan ultraso

192 shold visual acuity (VA), cover testing, and cycloplegic retinoscopy, performed by VIP-certified opto

193 were invited to follow-up a month later for cycloplegic retinoscopy, repeat noncycloplegic videorefr

194 eorefraction with repeat videorefraction and cycloplegic retinoscopy.

195 for refractive errors, measured by standard cycloplegic retinoscopy.

196 mponent of cycloplegic autorefraction versus cycloplegic retinoscopy.

197 eropia through cycloplegic autorefraction or cycloplegic retinoscopy.

198 tance visual acuity (VA), cover testing, and cycloplegic retinoscopy.

199 ant in some as compared to the tone found in cycloplegic retinoscopy.

200 Refractive status was confirmed with cycloplegic retinoscopy.

201 screening procedure, simpler to perform than cycloplegic screening, succeeded in detecting a large pr

202 However, the cycloplegic SE values demonstrated more negative values

203 SE measured 0.65 +/- 1.04 D more myopic than cycloplegic SE.

204 Myopia was defined as cycloplegic SER <= - 0.50 D.

205 0.16, P < 0.001), and the mean difference in cycloplegic SER at 12 months was + 1.25 D (PBM vs. Contr

206 he 12-month follow-up, the changes in AL and cycloplegic SER from baseline were both compared between

207 an age 9.7 years, 51% female), the mean (SD) cycloplegic SER was - 0.20 (2.18) D, and 1269 (36.9%) ha

208 Cycloplegic SER was significantly correlated with AL (Pe

209 However, the correlation between their cycloplegic shifts in SE was low (r = 0.2645).

210 ng a high (versus low) risk of myopia with a cycloplegic sphere cutoff of +0.75 D or less (versus mor

211 Cases were defined as 1. Myopia onset (cycloplegic spherical equivalent </= -0.5 diopter in non

212 The non-cycloplegic spherical equivalent (SE) did not differ sig

213 ewed at 26, 32 and 36 months, and changes in cycloplegic spherical equivalent (SE), axial length (AL)

214 The primary outcome was the 3-year change in cycloplegic spherical equivalent autorefraction, as meas

215 evels were not significantly associated with cycloplegic spherical equivalent or axial length after a

216 Cycloplegic spherical equivalent refraction and axial le

217 Observed changes in cycloplegic spherical equivalent refraction and axial le

218 An autorefractor was used to determine cycloplegic spherical equivalent refractive error (SPHEQ

219 dicted with moderate accuracy using the mean cycloplegic, spherical refractive error in the third gra

220 Myopia was defined as non-cycloplegic subjective spherical equivalent refraction <

221 conjunction with topical corticosteroid and cycloplegic therapy.